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Abstract
Background: Different histone post-translational modifications (PTMs) are crucial in the regulation of chromatin, including
methylations of H3 at Lysine 4 by the MLL complex. A relevant issue is how this is causally correlated to the binding of
specific transcription factors (TFs) in regulatory regions. NF-Y is a TF that regulates 30% of mammalian promoters containing
the widespread CCAAT element. We and others established that the presence of H3K4me3 is dependent upon the binding
of NF-Y. Here, we investigate the mechanisms of H3K4me3 deposition by NF-Y.
Methods: We employed Chromatin Immunoprecipitation in cells in which Ash2L and NF-Y subunits were knocked down by
RNAi, to monitor the presence of histones PTMs and components of the MLL complex. We performed gene expression
profiling of Ash2L-knocked down cells and analyzed the regulated genes. We performed ChIPs in leukemic cells in which
MLL1 is devoid of the methyltransferase domain and fused to the AF4 gene.
Results: Knock down of the Ash2L subunit of MLL leads to a decrease in global H3K4me3 with a concomitant increase in
H3K79me2. Knock down of NF-Y subunits prevents promoter association of Ash2L, but not MLL1, nor WDR5, and H3K4me3
drops dramatically. Endogenous NF-Y and Ash2L specifically interact in vivo. Analysis of the promoters of Ash2L regulated
genes, identified by transcriptional profiling, suggests that a handful TF binding sites are moderately enriched, among
which the CCAAT box. Finally, leukemic cells carrying the MLL-AF4 translocation show a decrease of H3K4me3, absence of
Ash2L and increase in H3K79me2, while NF-Y binding was not significantly affected.
Conclusions: Three types of conclusions are reached: (i) H3K4 methylation is not absolutely required for NF-Y promoter
association. (ii) NF-Y acts upstream of H3K4me3 deposition by recruiting Ash2L. (iii) There is a general cross-talk between
H3K4me3 and H3K79me2 which is independent from the presence of MLL oncogenic fusions.
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Introduction
Histone post-translational modifications -PTMs- are marks of
chromatin environments. Some of them are associated with
accessible chromatin, others with heterochromatin, either consti-
tutive or facultative [1]. Specifically, monoubiquitination of H2B
at Lysine 120 –K123 in yeast- is one of the earliest events in the
establishment of an active chromatin environment [2]. H3
methylations follow, on H3K4 and H3K79, in a hierarchy of
events that leads to gene activation. Methylation of H3K4 is highly
regulated [3] and generally present in active and poised promoters
[4]. The major H3K4 Methyltransferase is MLL (ALL1), the
human homologue of the Drosophila Trithorax, assembled in a
complex that includes Menin, Ash2L, WDR5, RbBP5, DPY30
and HCFs [5–7]. The 4 MLL genes in humans, MLL1-4 contain a
Set domain which mono-, di- and tri-methylates H3K4 [8];
proteins within the complex are important to impart substrate
specificity [9]. Specifically, the complex is unable to tri-methylate
H3K4 in the absence of Ash2L [6,7]. Moreover, MLL1 is involved
in chromosomal translocations with a large cohort of .50 loci in
aggressive myeloid and lymphoid leukemias [10].
In general, a key question is how histone modifying complexes
are selectively and timely recruited to promoters, and binding of
sequence-specific transcription factors offers a convenient expla-
nation [11–16]. NF-Y is a trimer composed of NF-YA, NF-YB and
NF-YC [17], which regulates the CCAAT box, one of the most
frequent and crucial promoter elements [18]. A connection
between NF-Y binding and H3K4 methylations was initially
noticed on the promoters of the ER-stress response genes, prior to
induction [19,20]. This was confirmed in genome-wide correlative
ChIP on chip studies, since NF-Y and H3K4me3 locations
overlapped significantly and correlated with expression [21]. In
cause-effect experiments, we and others noticed a parallel decrease
in NF-Y binding, H3K4me3, H3K79me2 and transcription using
a dominant negative NF-YA mutant [22–24]. The reverse was not
tested, namely whether H3K4me3 is important for NF-Y
promoter association. This is a relevant point, since not all TFs
are apparently equal in this regard: in a detailed correlative
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analysis, MYC binding was always associated with a specific
context of histone marks, notably H3K4me3 and H3K79me2, but
its removal –and comparison between myc+/+ and myc2/2 cells-
left the H3K4 pattern intact at target sites, whereas H4
acetylations were substantially ablated. Therefore, it was conclud-
ed that these marks are required for MYC binding to E boxes [25].
In a previous study focusing on cell cycle regulated promoters in
single nucleosome ChIP assays, we established that H3K4 di-
methylation is unaffected by NF-Y binding, which is instead
involved in the transition to mono- and tri-methylation upon gene
activation. We then focused on H3K4me1: NF-Y promotes it by
recruiting the CoREST-KDM1 H3K4me2 demethylase complex
through contacts between NF-Y and CoREST [24]. Here, we
report studies on the deposition of the H3K4me3 mark on
CCAAT promoters. In particular, we first tested the hypothesis
that H3K4me3 might be generally helpful in NF-Y promoter
association, by eliminating Ash2L, the one subunit of the complex
that is specifically required for the deposition of this mark.
Results
Knock down of Ash2L leads to decrease in H3K4me3,
increase in H3K79me2 and selective reduction of NF-Y
binding
To study the role of H3K4me3 in NF-Y promoter association,
we knocked down Ash2L by siRNA in HCT116 cells: Figure 1A
shows that a substantial reduction of Ash2L –down to 30% of
normal levels- could be achieved, while other subunits of MLL
complexes, Menin and WDR5, were, if anything, increased
(Fig. 1A). Global levels of H3K4 methylations were controlled by
Western blot analysis: H3K4me3 reduction by Ash2L siRNA was
matched by an increase of H3K4me2, while H3K4me1 was
unchanged (Fig. 1A, Lower Panels). Next, we performed ChIP
experiments with chromatin of HCT116 cells treated with control
and Ash2L siRNAs, using antibodies against NF-Y, H3K4me3,
H3K4me2, H3K79me2 and Ash2L; we analyzed a few promoters
that are representatives of the different classes of CCAAT
promoters -housekeeping, cell cycle and ER-stress- as well as of
promoters devoid a of the CCAAT box -CCAAT-less- serving as
controls. In parallel, we analyzed the transcriptional profile of the
genes considered. Fig. 1B shows a two to four-fold decrease of
H3K4me3 on most promoters, with the exception of TICAM2
and ERP70. Interestingly, H3K79me2 levels were concomitantly
increased (2 to 3-fold): indeed, the greater the loss of H3K4me3,
the higher the increase of H3K79me2. NF-Y binding was
decreased on some promoters -ERP70, CHOP, PCNA but not
abolished. In most other promoters, however, the decrease in NF-
Y binding was marginal. We conclude that the presence of
H3K4me3 moderately influences NF-Y binding only on some
promoters, and that indirect removal of H3K4me3 by inactivation
of Ash2L leads to a compensatory positive effect on H3K79me2.
NF-Y recruits Ash2L on CCAAT-containing promoters
Removal of the NF-Y trimer from cell cycle promoters by an
NF-YA dominant negative mutant led to a substantial decrease of
H3K4 tri-methylation [22–24], which is dependent from Ash2L,
but not H3K4 di-methylation. One possibility is that NF-Y is
important specifically for Ash2L recruitment. To establish this
point, we decided to use an alternative system: knock down of the
NF-YB (Fig. 2A) and of NF-YA (Fig. 2B) subunits in HCT116 cells
by shRNA interference. Western blot analysis of NF-Y subunits
confirmed the selective reduction of the respective NF-Y subunits:
to 30% for NF-YB and 27% for NF-YA. Ash2L, as well as the
global levels of H3K4me3 were not affected. ChIP assays on the
NF-Y-dependent promoters analyzed in Fig. 1 showed a parallel
reduction of NF-YB, H3K4me3 and Ash2L, whereas the presence
of MLL1 and WDR5 was unaffected. On the control CCAAT-less
UNG, COA5 and TICAM2 promoters, no NF-Y binding and
robust Ash2L association was evident (Fig. 2A and 2B); MDM2,
instead, showed a drop in Ash2L: a possible interpretation is that
an important NF-Y site in a distant region impacts on promoter
organization affecting H3K4me3.
To ascertain whether there is a NF-Y-Ash2L interaction in vivo,
we performed immunoprecipitations with NF-Y and Ash2L
antibodies with HCT116 nuclear extracts, followed by Western
blot analysis. Fig. 3 shows that Ash2L is immunoprecipitated with
anti-NF-YB antibodies, whereas minimal levels of Menin and
WDR5 were present in the bound fraction. The reciprocal was
also true, as substantial amounts of NF-YA was in the Ash2L IP.
Control IPs were negative for all proteins tested. Taken together,
these data indicate that the recruitment of Ash2L is dependent
upon NF-Y binding, that there is a NF-Y-Ash2L interaction in vivo,
and that other subunits of the MLL complex are recruited
independently from Ash2L.
To ascertain whether Ash2L is recruited preferentially on
CCAAT promoters, we performed expression profiling of
HCT116 cells after knock down of Ash2L by siRNA, with the
protocol shown above in Fig. 1. By setting the threshold at 1.35,
477 genes were down-regulated and 175 up-regulated (Fig. S1).
We validated by qRT-PCR 32 of these genes, and the adherence
to the gene expression data was almost complete (Fig. 4A). The
overall greater changes observed by qRT-PCR analysis suggest
that additional genes below the threshold considered are affected
by Ash2L interference. Analysis of Gene Ontology terms indicates
that Ash2L targets different classes of genes, with DNA and RNA
Metabolism being dominant in the Biological Process and Molecular
Function categories (Fig. 4B). We then analyzed the regulated
promoters to identify enriched Transcription Factor Binding Site -
TFBS- (Figure S2): CCAAT was indeed at a top of a short list of
sites, together with a few other, but the p values were relatively
modest, an indication that there is no strong skewing toward a
specific TFBS. We conclude that Ash2L recruitment on CCAAT
promoters is NF-Y-dependent, but that the function of this MLL
subunit is not restricted to CCAAT promoters.
Ash2L promoters association is affected in Mixed Lineage
Leukemia cells
The results shown above indicate that NF-Y lies upstream of
Ash2L recruitment and H3K4me3 deposition. Previous data on
cell cycle genes indicate that H3K4me2 is present independently
Figure 1. Effects of Ash2L knock down on H3K4me3, H3K79me2 and NF-Y binding. A. Knock down of Ash2L in HCT116 human cells.
Western blot analysis of the indicated proteins and histone PTMs in cells transfected with scramble and Ash2L siRNAs. On the right, the levels of
Ash2L protein inactivation, based on three independent experiments. B. In the upper Panel, mRNAs levels of the indicated genes in HCT116 cells
transfected with scramble (Grey bars) or Ash2L siRNAs (Black bars) were assessed by qRT-PCR. In the lower Panels, Chromatin immunoprecipitation
(ChIP) analysis was performed with the indicated antibodies (NF-YB, H3K4me2, H3K4me3, H3K79me2) in the same cells transfected with scramble or
Ash2L siRNA. qPCR analysis was performed with primers centered in the core promoters of the indicated genes. CCAAT-less refers to genes with no
CCAAT box in the promoters. Cell cycle and ER-stress are two categories of promoters with functionally important CCAAT boxes.
doi:10.1371/journal.pone.0017220.g001
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from NF-Y, raising the possibility that this mark is actually
required for NF-Y recruitment. To further evaluate this point, we
used the cell line RS4-11, derived from a Mixed Lineage
Leukemia, which contains a rearrangement of the MLL1 gene
with AF4: as in other MLL1 fusions, it lacks the SET domain and
it is therefore devoid of H3K4 methylating activity (10). Note that
in MLL-AF10 regulated genes, this is compensated by higher
levels of H3K79me2 [26–28], which is also under the control of
NF-Y [22,24]. Therefore, we first evaluated the global levels of the
proteins and histone PTMs considered in this study in RS4-11,
showing that they were largely similar to what is found in REH, a
control leukemia cell line that harbours normal MLL1 alleles
(Fig. 5A). We then analyzed by ChIPs NF-Y, Ash2L and H3K4
methylations on CCAAT promoters, in RS4-11 and REH. The
levels of H3K4me3 were lower in RS4-11 compared to REH on
most, but not all promoters (Fig. 5B). Higher levels of H3K79me2
were found, specifically in the promoters with low levels
H3K4me3, which is consistent with previous results with MLL-
AF10 fusions [26–28]. The H3K4me1 and H3K4me2 levels were
extremely low in RS4-11, with the exception of CKS2 and Cyclin
B1 promoters. Importantly, the recovery of Ash2L were minimal
from all promoters, while NF-Y binding was comparable in the
two cell lines, including in promoters with residual levels of H3K4
methylations. We take this as a further indication that H3K4
methylations are not strictly required for NF-Y association. In
addition, it is clear that the presence of the oncogenic fusion
protein affects the levels of H3K4 mono-, di- and tri-methylation.
Discussion
NF-Y and H3K4 methylations
A relevant question in chromatin studies is what determines the
location of histone marks on genomes. The binding of TFs and
cofactors to promoters are hallmarks of expression, by signalling to
the Pol II machinery the appropriate positional coordinates. In
general, it seems plausible that TFs are instrumental in
determining the positions of specific histone PTMs. However, it
is becoming increasingly clear that certain TFs do require a
particular set of histone TFs to access regulatory regions: MYC
binding, for example, happens only in sites in which H3K4 and
H3K79 methylations are abundant [25]. Hence, there must be a
hierarchy in TF in establishing a certain chromatin environment,
with some TFs being capable to recruit histone modifying enzymes
for the benefit of additional TFs. There is a strong correlation in
genomic locations of NF-Y and H3K4me3, and removal of NF-Y
reduced the local, but not the global levels of H3K4me3 [19-24].
Unlike other TFs, the presence of high levels of H3K4me3 is not
strictly required for NF-Y recruitment: indeed, NF-Y is involved in
the recruitment of Ash2L, indicating that it acts upstream of
H3K4me3, and placing it at the heart of the local di- to tri-
Figure 2. NF-Y recruits Ash2L on CCAAT-containing promoters. A. Knock down of the NF-YB subunit in HCT116 human cells by infection
with control (GFP) or NF-YB shRNA producing Lentiviruses. Left Panels: Western blot analysis of the indicated proteins and histone PTMs, with a
statistical evaluation of the degree of NF-YB protein knock down, measured based on three independent experiments. Right Panels: in the upper
Panel, mRNAs levels of the indicated genes in HCT116 cells transfected with control GFP (Grey bars), or NF-YB shRNAs (Black bars) assessed by qRT-
PCR. In the lower Panels, Chromatin immunoprecipitation (ChIP) analysis was performed with the indicated antibodies (NF-YB, H3K4me3, Ash2L,
MLL1, WDR5) in the same cells. qPCR analysis was performed with primers centered in the core promoters of the genes. The same set of promoters of
Figure 1 were analyzed. B. Same as A, except that cells were knocked down with shRNA for NF-YA.
doi:10.1371/journal.pone.0017220.g002
Figure 3. Direct interaction between NF-Y and Ash2L. Western blot analysis of immunprecipitations with anti-NF-YB (Left Panel) and anti-
Ash2L (Right Panel) antibodies, using acid-extracted nuclear extracts of HCT116 cells. Control IPs with anti-Flag antibodies were run in parallel. The
Load lane refers to the starting nuclear extract material. Menin and WDR5 were marginally immunoprcipitated with anti-NF-YB, whereas Ash2L
recovery was robust. The heavy (IgH) and light (IgL) chains of the IP antibodies are indicated.
doi:10.1371/journal.pone.0017220.g003
NF-Y and Ash2L
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methylation transition. Furthermore, the results in MLL cells, in
which most promoters we analyzed have residual levels of any
H3K4 methylation, yet robust NF-Y association, indicate that
none of the methylations of H3K4 is strictly required for binding
of the trimer to DNA. The fact that H3K4 methylations are
downstream of H2B monoubiquitination ([2] and References
therein] renders the H2B-like structure of NF-YB particularly
relevant, since a parallel signalling can be envisaged.
The presence of the CCAAT box at the top of the list of the
Ash2L regulated genes, together with few other TFBS with similar
scores, is in line with the data. However, the relatively low
statistical enrichments in TFBS analysis among Ash2L-regulated
promoters indicate that the preference is not absolute, and many
other TFs can recruit Ash2L, as indicated by genetic screenings for
interactors of AP2, Mef2c, PAX7 and Tbx1 [13–16]. We confirm
that removal of Ash2L leads to a drastic decrease in the global
Figure 4. Validation of Ash2L profiling experiments. A. Validation of the profiling data for selected genes whose expression was activated or
repressed by Ash2L inactivation, as in the experiments shown in Figure 1, was performed by qRT-PCR. B. Gene Ontology analysis of the profiling
experiments of Ash2L-dependent genes.
doi:10.1371/journal.pone.0017220.g004
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levels of H3K4me3, while H3K4me2 and H3K4me1 are not
substantially changed. Whether Ash2L is the only subunit of the
complex to direct the MLL activity toward trimethylation is
currently unclear [9]. As Ash2L is believed to be present in
complexes containing different MLLs, we were surprised by the
relatively low number of genes affected by Ash2L interference.
There are technical explanations for this, such as the incomplete
elimination of the protein and the fact that hybridization-derived
profiling data are less sensitive to variation with respect to qRT-
PCR, suggesting that many additional genes were indeed missed.
In addition, the presence of partially redundant activities similar to
Ash2L, such as Ash1 [29], should be considered.
Reciprocal regulation of H3K4me3 and H3K79me2
MLL is a complex and genetically heterogeneous disease in
which MLL1 fusion proteins alter gene expression; this is, in part,
due to the partners, some of which -AF4, AF9 and ENL- have
transcription activation domains required for transformation
Figure 5. MLL cells lack Ash2L promoter association. A. Western blot analysis of the levels of the indicated proteins (Ash2L, NF-Y subunits,
global H3, H3K4me1, H3K4me2, H3K4me3, H3K79me2, and the internal control Vinculin) in MLL1-AF4 rearranged cells RS4-11 and in non MLL1
rearranged REH leukemic cells. B. In the upper Panel, mRNAs levels of the indicated genes in REH (Black bars) and RS4-11 (Grey bars) assessed by qRT-
PCR. In the lower Panels, Chromatin immunoprecipitation (ChIP) analysis was performed with the indicated antibodies (NF-YB, Ash2L, H3K4mei,
H3K4me2, H3K4me3, H3K79me2) in the same cells. qPCR analysis was performed with primers centered in the core promoters of the genes. The same
set of promoters of Figure 1 were analyzed.
doi:10.1371/journal.pone.0017220.g005
NF-Y and Ash2L
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[10,27]. In cells bearing AF10 fusions, reduced H3K4me3 was
reported to be ‘‘compensated’’ by high H3K79me2 levels. AF10
was shown to bind to hDOT1L, through a domain required for
transformation [28]. In accordance with these data, in our analysis
of leukemic cells with an MLL1-AF4 fusion, the H3K4me3
decrease is also ‘‘compensated’’ by an increase in H3K79me2.
However, in HCT116 cells, which carry a wt MLL1 configuration,
the removal of Ash2L alone, by decreasing H3K4me3, is sufficient
to increase H3K79me2, and there is an inverse correlation
between these two marks on each of the promoters we analyzed.
One could therefore hypothesize that it is the absence of Ash2L on
promoters, rather than, or in addition to an AF4 or AF10-
mediated recruitment of hDOT1L, which leads to high
H3K79me2 levels. This finding could have consequences in the
temporal deposition of the two marks, which lie downstream of
H2BUb, suggesting that H3K79me2 acts upstream of H3K4me3.
This matter is further complicated by the fact that mono- and di-
methylations are also dramatically affected in MLL cells, which
was somewhat expected, based on the assumption that the SET
domain is absent from the MLL fusions, but never tested.
Importantly, in the absence of the N-terminal end of MLL1,
Ash2L is not recruited onto promoters. These data indicate that
the oncogenic potential might be influenced by the variation of
composition of the MLL complex as a whole, as well as by the
presence of the fusion partner.
A link between the MLL complex and NF-Y in cellular
transformation?
In 23 acute lymphoblastic leukemias with MLL translocations,
two signatures correlating with prognosis were found [30]. Top
rank genes were HspCBF, an NF-Y coactivator [31] in the poor
prognosis group, and CDP, a negative regulator of CCAAT
activity [32], in the cohort with good prognosis. Importantly, genes
with two CCAAT boxes, predicted to be down-regulated by CDP,
were found underexpressed in the latter group. (ii) The CCAAT
box was repeatedly reported, along with E2F sites, in genes
specifically overexpressed in tumors [33–35]. Notably, de novo
motifs discovery in leukemias pointed at three sites: the expected
E2F-NF-Y duo and p53 [36]. (iii) Analysis of gene expression
profiles of MLL-AF9 leukemias identified a haematopoietic stem
cell -HSCs- signature that confers self-renewal properties [10],
with some targets, such as HOXA members, important for tumor
growth. Interestingly, NF-Y was shown to be a potent HSC self-
renewal regulator, by activating HOX4 paralogues [37]. Notably,
the short form of NF-YA appears to be crucial [38,39]. Thus,
MLL fusions and NF-Y could work together in reactivation of a
self-renewal program. The absence of significant levels of H3K4
methylations is coupled to high levels of H3K79me2, a mark also
dependent from the presence of NF-Y [24]: we can imagine that
NF-Y is also involved in the recruitment of the hDOT1 complex,
even without the presence of the AF4/AF10 fusion partner. NF-Y-
mediated recruitment of MLL complexes with an altered
composition on growth-promoting genes could impair profoundly
regulation, via alteration of the local histone PTMs. Further
biochemical and in vivo ChIP work is required to shed light on this
hypothesis.
Materials and Methods
Cell cultures and transfections
HCT116 cells were cultured in DMEM supplemented with
10% FCS, 1% penicillin and streptomycin, and L-glutamine. All
transfections were carried out using Lipofectamine 2000 (Invitro-
gen, USA). The Ash2L siRNA was purchased by (Dharmacon,
USA). Scrambled siRNA was used as a negative control (Ambion,
USA). NF-YA and NF-YB shRNA vectors were purchased from
Sigma; the control was a similar vector expressing shRNA against
GFP.
RT-PCR analysis, Nuclear and Acid extracts preparation
and Western blot analysis
Total RNAs were extracted using an RNA-Easy kit (Qiagen, D).
1mg of each RNA was retrotranscribed (Promega, USA).
Normalization of the cDNAs were performed with GAPDH
control. The RT-PCR primers used are listed in Figure S3.
Nuclear extracts were prepared according to standard proce-
dures (20). Acid extracts were prepared collecting cells in 5–10
volumes of Lysis Buffer H (10 mM Hepes pH 7.9, 150 mM
MgCl2, 10 mM KCl, 0.5 mM DTT, 1.5 mM PMSF); Perchloric
acid 0.2 M was added and cells were kept on ice for 30 minutes,
followed by centrifugation for 10 minutes at 11000 g at 4uC; the
supernatants were stocked at 280uC. 15 mg of nuclear and acid
extracts were used in 12% SDS-PAGE. Proteins were transferred
to nitrocellulose membranes and immunoblotted using the
antibodies of interest. The protein-antibody complexes were
detected using horseradish peroxidase-conjugated secondary
antibodies (GE Healthcare, UK) and the chemioluminescence
system (Genespin, I).
Chromatin Immunoprecipitation
ChIP assays were performed as previously described (Donati et al,
2007). Immunoprecipitations were performed with ProtG-Sephar-
ose (KPL, USA) and 3mg of the following antibodies: NF-YB
(Genespin, I); H3 (Abcam 1791); H4K4me3 (Abcam 8580, Active
Motif 39159); H4K4me2 (Abcam 7766); H4K4me1 (Abcam 8895);
H3K79me2 (Abcam 3594), Ash2L (Active Motif 39099). The MLL
antibody was a kind gift of E. Canaani (Weizman I., Il). The ChIP-
PCR primers are listed in Figure S3. Quantitative Real Time PCR
was performed using SYBR green IQ reagent (Biorad, USA) in the
iCycler IQ. The relative sample enrichment was calculated with the
following formula: 2 DCtx -2 DCtb, where DCt x = Ct input-Ct
sample and DCt b = Ct input-Ct control Ab.
Supporting Information
Figure S1 List of Ash2L-regulated genes in HCT116 cells.
Genes whose expression is altered upon Ash2L knock down.
(DOC)
Figure S2 Transcription Factor Binding Site (TFBS) analysis of
the promoters (-500/+100 from the Transcriptional Start Site) of
the Ash2L-regulated genes derived from the profiling experiments.
(DOC)
Figure S3 List of primers used in q-RT-PCR and ChIPs.
(PDF)
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